Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · American Healthcare REIT (AHR)

American Healthcare REIT raises 2026 NFFO guidance as Q1 net income turns positive

Mixed Impact 4 of 5 earnings Written later

American Healthcare REIT (NYSE: AHR) reported first quarter 2026 GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share, compared with a loss of $6.8 million a year earlier. It raised its full-year 2026 NFFO per diluted share guidance to $2.03 to $2.09, but lowered its full-year net income per diluted share guidance to $0.51 to $0.57 from $0.75 to $0.81.

Key points

  • Q1 2026 total revenues were $650.8 million, up from $540.6 million in Q1 2025; NFFO was $0.50 per diluted share, up from $0.38.
  • FY2026 NFFO per diluted share guidance rose to $2.03 to $2.09 from $1.99 to $2.05, and total portfolio Same-Store NOI growth guidance rose to 9.0% to 12.0% from 7.0% to 11.0%.
  • FY2026 net income per diluted share guidance fell to $0.51 to $0.57 from $0.75 to $0.81.
  • Net Debt-to-Annualized Adjusted EBITDA improved to 3.0x at March 31, 2026, from 3.4x at December 31, 2025.

The filing

CompanyAmerican Healthcare REIT (AHR)
Form8-K, current report
Filed with the SECMay 7, 2026, 4:20 PM ET
Accession number0001193125-26-212023

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.